Tag: mesalamine

June 25, 2019 Off

Amring Pharmaceuticals launches two pharmaceutical generics to the US market

Amring Pharmaceuticals, a generic pharmaceutical and ophthalmic medical device company, announced today that it has launched two valued drugs into its generic portfolio and to the U.S. Market.

May 10, 2019 Off

Teva launches generic Delzicol delayed-release capsules in the United States

By BusinessWire

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) todayannounced the launch of a generic version of Delzicol®1(mesalamine) delayed-release capsules, 400 mg, in the U.S.